Scholarlink

Objectives <p>To compare the oral manifestations among diabetic and non-diabetic patients affected with COVID-19.</p> Methodology <p>A cross-sectional study was conducted among 156 RT-PCR-confirmed COVID-19 patients who were divided into diabetic (76) and non-diabetic groups (80). Statistical analyses were performed using IBM SPSS 22V. The Pearson chi-square test was used to compare the prevalence of oral manifestations associated with COVID-19 among diabetic and non-diabetic patients.</p> Results <p>Oral manifestations such as loss of taste (86.8% vs. 61.3%, <i>p</i> &lt; 0.001), mouth ulceration (38.2% vs. 12.5%, <i>p</i> &lt; 0.001), bleeding while brushing (35.5% vs. 12.5%, <i>p</i> &lt; 0.001), and lip swelling (11.8% vs. 2.5%, <i>p</i> = 0.022) were significantly high except for oral fungal infection (2.6% vs. 0%, <i>p</i> = 0.143) in diabetic COVID-19 patients when compared with non-diabetic COVID-19 patients. Furthermore, diabetic COVID-19 patients had a higher hospitalization rate (30.3% vs. 12.5%, <i>p</i> = 0.006) and systemic symptoms.</p> Conclusions <p>The prevalence of oral and systemic manifestations, as well as hospitalization, was higher among COVID-19 patients with diabetes compared to those without diabetes. These outcomes might be influenced by factors such as poor oral hygiene and hyperglycemia, which can exacerbate the severity of symptoms.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Oral Manifestations in COVID-19: A Comparative Analysis of Diabetic and Non-diabetic Patients in South India

  • 期刊论文

  • 发表日期：

    2025年2月17日

查看全文
  • Gopika Mohanakumaran Nair Geetha,
  • H. Gladius Jennifer,
  • Smrithi Anna Punnen

摘要

Objectives

To compare the oral manifestations among diabetic and non-diabetic patients affected with COVID-19.

Methodology

A cross-sectional study was conducted among 156 RT-PCR-confirmed COVID-19 patients who were divided into diabetic (76) and non-diabetic groups (80). Statistical analyses were performed using IBM SPSS 22V. The Pearson chi-square test was used to compare the prevalence of oral manifestations associated with COVID-19 among diabetic and non-diabetic patients.

Results

Oral manifestations such as loss of taste (86.8% vs. 61.3%, p < 0.001), mouth ulceration (38.2% vs. 12.5%, p < 0.001), bleeding while brushing (35.5% vs. 12.5%, p < 0.001), and lip swelling (11.8% vs. 2.5%, p = 0.022) were significantly high except for oral fungal infection (2.6% vs. 0%, p = 0.143) in diabetic COVID-19 patients when compared with non-diabetic COVID-19 patients. Furthermore, diabetic COVID-19 patients had a higher hospitalization rate (30.3% vs. 12.5%, p = 0.006) and systemic symptoms.

Conclusions

The prevalence of oral and systemic manifestations, as well as hospitalization, was higher among COVID-19 patients with diabetes compared to those without diabetes. These outcomes might be influenced by factors such as poor oral hygiene and hyperglycemia, which can exacerbate the severity of symptoms.